Loncastuximab (RB4v1.2) is a monoclonal antibody inhibitor targeting CD19 with antitumor activity. It is used in research on non-Hodgkin lymphoma (NHL) and diffuse large B-cell lymphoma (DLBCL), and for synthesizing ADC molecules such as Loncastuximab tesirine.
Reinheit:
95.90%
CAS Nummer:
[1875032-68-0]
Target-Kategorie:
Immunology/Inflammation related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten